Publications by authors named "Boris Nikonenko"

Claim this Profile
I
Indole triazene compound TU112 demonstrates in vitro activity against dormant Mycobacterium tuberculosis and efficacy against chronic tuberculosis infection in mice.
Margarita O Shleeva, Boris V Nikonenko, Konstantin B Majorov, Pavel Yu Ivanov, Alexander S Apt

Tuberculosis (Edinb)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of macozinone in mice with genetically diverse susceptibility to Mycobacterium tuberculosis infection.
Boris Nikonenko, Nadezhda Logunova, Anna Egorova, Marina Kapina, Natalia Sterzhanova

Microbes Infect· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic Fate of Human Immunoactive Sterols in Mycobacterium tuberculosis.
Tatsiana Varaksa, Sergey Bukhdruker, Irina Grabovec, Egor Marin, Anton Kavaleuski, Boris Nikonenko

J Mol Biol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural Modifications of 3-Triazeneindoles and Their Increased Activity Against .
Konstantin B Majorov, Boris V Nikonenko, Pavel Yu Ivanov, Lyudmila N Telegina, Alexander S Apt

Antibiotics (Basel)· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new model for chronic and reactivation tuberculosis: Infection with genetically attenuated Mycobacterium tuberculosis in mice with polar susceptibility.
Tatiana K Kondratieva, Marina A Kapina, Elvira I Rubakova, Elena V Kondratieva, Boris V Nikonenko

Tuberculosis (Edinb)· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New 1-hydroxy-2-thiopyridine derivatives active against both replicating and dormant Mycobacterium tuberculosis.
Elena G Salina, Olga Ryabova, Anthony Vocat, Boris Nikonenko, Stewart T Cole

J Infect Chemother· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vitro Activity of 3-Triazeneindoles against Mycobacterium tuberculosis and Mycobacterium avium.
Boris V Nikonenko, Albert Kornienko, Konstantin Majorov, Pavel Ivanov, Tatiana Kondratieva

Antimicrob Agents Chemother· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Clostridium difficile infection using SQ641, a capuramycin analogue, increases post-treatment survival and improves clinical measures of disease in a murine model.
John H Moore, Edward van Opstal, Glynis L Kolling, Jae Hyun Shin, Elena Bogatcheva, Boris Nikonenko

J Antimicrob Chemother· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and antituberculosis activity of indole-pyridine derived hydrazides, hydrazide-hydrazones, and thiosemicarbazones.
Valeriya Velezheva, Patrick Brennan, Pavel Ivanov, Albert Kornienko, Sergey Lyubimov, Boris Nikonenko

Bioorg Med Chem Lett· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic efficacy of SQ641-NE against Mycobacterium tuberculosis.
Boris Nikonenko, Venkata M Reddy, Elena Bogatcheva, Marina Protopopova, Leo Einck

Antimicrob Agents Chemother· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Latent tuberculosis infection: what we know about its genetic control?
Tatiana Kondratieva, Tatyana Azhikina, Boris Nikonenko, Arseny Kaprelyants, Alexander Apt

Tuberculosis (Edinb)· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic helminth infection does not exacerbate Mycobacterium tuberculosis infection.
Marc P Hübner, Kristin E Killoran, Michael Rajnik, Samuel Wilson, Kevin C Yim, Boris Nikonenko

PLoS Negl Trop Dis· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug testing in mouse models of tuberculosis and nontuberculous mycobacterial infections.
Boris V Nikonenko, Alexander S Apt

Tuberculosis (Edinb)· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of SQ609 as a lead compound from a library of dipiperidines.
Elena Bogatcheva, Colleen Hanrahan, Boris Nikonenko, Gladys de los Santos, Venkata Reddy

Bioorg Med Chem Lett· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-tuberculosis drug therapy in mice of different inbred strains.
Boris V Nikonenko, Leo Einck, Carol A Nacy

Infect Genet Evol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of SQ641, a capuramycin analog, in a murine model of tuberculosis.
Boris V Nikonenko, Venkata M Reddy, Marina Protopopova, Elena Bogatcheva, Leo Einck

Antimicrob Agents Chemother· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of late tuberculosis infection in Sigmodon hispidus.
Robert L Elwood, Michael Rajnik, Samuel Wilson, Kevin Yim, Jorge C G Blanco, Boris Nikonenko

Tuberculosis (Edinb)· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical study of new TB drugs and drug combinations in mouse models.
Boris V Nikonenko, Katherine A Sacksteder, Sam Hundert, Leo Einck, Carol A Nacy

Recent Pat Antiinfect Drug Discov· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In search of new cures for tuberculosis.
Marina Protopopova, Elena Bogatcheva, Boris Nikonenko, Sam Hundert, Leo Einck

Med Chem· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug therapy of experimental tuberculosis (TB): improved outcome by combining SQ109, a new diamine antibiotic, with existing TB drugs.
Boris V Nikonenko, Marina Protopopova, Rowena Samala, Leo Einck, Carol A Nacy

Antimicrob Agents Chemother· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The American cotton rat: a novel model for pulmonary tuberculosis.
Robert L Elwood, Samuel Wilson, Jorge C G Blanco, Kevin Yim, Luba Pletneva, Boris Nikonenko

Tuberculosis (Edinb)· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of new diamine scaffolds with activity against Mycobacterium tuberculosis.
Elena Bogatcheva, Colleen Hanrahan, Boris Nikonenko, Rowena Samala, Ping Chen

J Med Chem· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and optimization of a recombinant system for large-scale production of the MPT64 antigen from Mycobacterium tuberculosis.
Brian V Geisbrecht, Boris Nikonenko, Rowena Samala, Reiko Nakamura, Carol A Nacy

Protein Expr Purif· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines.
Marina Protopopova, Colleen Hanrahan, Boris Nikonenko, Rowena Samala, Ping Chen

J Antimicrob Chemother· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamics and pharmacokinetics of SQ109, a new diamine-based antitubercular drug.
Lee Jia, Joseph E Tomaszewski, Colleen Hanrahan, Lori Coward, Patricia Noker, Boris Nikonenko

Br J Pharmacol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis